[BULLISH]: Assembly Biosciences current trading has maintained the Commodity Channel Index to oversold status and signalled the continuation of the bullish trading conditions. Currently, the CCI is -121. The bullish signal has been active for 6 days. During the quarter, the lowest CCI value was -261.
The Commodity Channel Index indicator takes a security’s change in price and compares that to its average change in price. CCIs calculation produces positive and negative values that oscillate above and below a Zero Line. Typically a value of 100 is identified as overbought and a reading of -100 is identified as being oversold.
Calculation: 20 Period CCI:
1) CCI = (Typical Price - 20 Period SMA of TP) / (.015 x Mean Deviation);
2) Typical Price (TP) = (High + Low + Close)/3;
PROFILE: Assembly Biosciences (ASMB)
Stock Exchange: NASDAQ
Company: Assembly Biosciences
Ticker Codes: | ASMB | NASDAQ:ASMB |
Assembly Biosciences, Inc. operates as a clinical stage biotechnology company. It develops oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutic candidates to treat disorders associated with the microbiome in the United States. It is involved in the development of core protein allosteric modulators that modulate the HBV core protein at various points in the viral lifecycle. The company also develops microbiome program, a platform that includes the identification and selection process to strain isolation and growth under current good manufacturing practice conditions; and a patent pending delivery system, GEMICEL, which allows for targeted oral delivery of live biologic and conventional therapies to the lower gastrointestinal tract. In addition, it engages in the development of product candidates for various disease indications, such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, non-alcoholic steatohepatitis, immuno-oncology, and clostridium difficile infections by using its microbiome platform. It has a collaboration agreement with Allergan Pharmaceuticals International Limited for the development and commercialization of selected microbiome gastrointestinal programs. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was founded in 2005 and is headquartered in Carmel, Indiana.
Commodity Channel IndexDownload
|DHXM DHX Media Ltd||1.07||6.1||210,438||-109||BULLISH|
|COLL Collegium Pharma||14.87||4.3||373,509||-126||BULLISH|
|AOSL Alpha And Omega Semi||12.29||2.2||82,608||-121||BULLISH|
|EXTR Extreme Networks||5.72||1.6||1,066,956||-107||BULLISH|
|MCRB Seres Theraptc||7.53||1.6||171,748||-118||BULLISH|
|FRBK Republic First Bancorp||7.2||1.4||155,206||-123||BULLISH|
|HBAN Huntington Bcshs||15.72||1.4||10,164,976||-123||BULLISH|
|MCHP Microchip Technology||81.37||1.2||2,309,614||-133||BULLISH|